Biotech

All Articles

Biogen containers SAGE-324 partnership after necessary agitation fail

.Biogen has actually conducted the final ceremonies to its cooperation along with Sage Therapeutics ...

AbbVie Parkinson's medication from $8.7 B Cerevel acquistion scores

.On the exact same time that some Parkinson's ailment drugs are actually being brought into question...

Arch finalizes $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Capital Lifestyle Sciences, Arch Venture Partner...

Orion to utilize Aitia's 'digital twins' to find new cancer cells drugs

.Finnish biotech Orion has actually spied prospective in Aitia's "digital twin" specialist to build ...

Windtree's surprise med increases high blood pressure in most current phase 2 succeed

.While Windtree Therapies has actually struggled to increase the monetary roots needed to make it th...

2 cancer biotechs merge, making international impact

.OncoC4 is actually taking AcroImmune-- and its own in-house medical manufacturing abilities-- under...

Amgen records very first period 3 gain for $400M chronic eczema medicine

.Amgen has shared (PDF) the 1st stage 3 records on its own $400 million eczema drug, linking the ant...

Biogen, UCB report stage 3 lupus gain after neglecting earlier trial

.Biogen and UCB's gamble on advancing into period 3 astride a failed research study hopes to have pa...

Aptadir really hopes brand-new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Therapies has actually introduced along with the guarantee that its own pip...

Wave surfs DMD results to regulators' doors, sending stock up

.Surge Life Sciences has met its target in a Duchenne muscle dystrophy (DMD) study, placing it to sp...